Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2024 Financial Results. At this time, all participants are in a listen-only mode. After the speakers' ...

Good morning, everybody. We're waiting for the few final people to pop into the conference, and we'll get started in just a few seconds. Everybody has joined the conference. So Randy, good to go.

Legend Biotech’s Q1 2026 EPS of -$0.15 fell short of the $0.01 forecast. Revenue reached $305.1 million, slightly below expectations. The stock surged 12.08% pre-market despite the earnings miss.

Legend Biotech missed both EPS and revenue forecasts for Q1 2026. The company’s gross margin declined significantly due to one-time manufacturing costs. CARVYKTI sales showed strong year-over-year ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2024 Financial Results. At this time, all participants are in a listen-only mode. After the ...

Read Legend Power Systems Inc. (XLE1.SG) Q4 FY2025 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...

Legend Biotech Corporation beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.56. Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Legend Biotech ...

Legend Biotech (LEGN) is scheduled to announce Q3 earnings results on Tuesday, November 11th, before market open. The consensus EPS Estimate is -$0.12 (+64.7% Y/Y) and the consensus Revenue Estimate ...